诺诚健华-U
(688428)
| 流通市值：64.15亿 | | | 总市值：424.60亿 |
| 流通股本：2.66亿 | | | 总股本：17.63亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 381,263,139.35 | 1,009,448,013.44 | 697,748,228.93 | 419,737,910.92 |
| 营业收入 | 381,263,139.35 | 1,009,448,013.44 | 697,748,228.93 | 419,737,910.92 |
| 二、营业总成本 | 383,940,887.34 | 1,463,013,205.36 | 975,965,605.67 | 679,410,003.05 |
| 营业成本 | 36,066,440.09 | 138,441,152.27 | 98,028,598.02 | 60,139,759.03 |
| 税金及附加 | 6,989,137.1 | 15,235,964.22 | 10,737,102.16 | 6,641,312.43 |
| 销售费用 | 114,012,126.98 | 419,960,584.26 | 273,927,859.06 | 157,153,114.33 |
| 管理费用 | 42,762,733.27 | 168,528,403.9 | 125,820,073.29 | 84,975,021.7 |
| 研发费用 | 207,599,189.43 | 814,609,352.61 | 614,983,375.71 | 421,404,233.69 |
| 财务费用 | -23,488,739.53 | -93,762,251.9 | -147,531,402.57 | -50,903,438.13 |
| 其中:利息费用 | 13,518,113.67 | 33,794,672.67 | 20,557,333.16 | 10,471,937.88 |
| 其中:利息收入 | 33,751,558.37 | 171,589,406.1 | 138,559,308.84 | 94,559,141.39 |
| 加:公允价值变动收益 | 2,560,936.02 | -30,462,084.77 | -29,423,716.12 | -23,256,781.3 |
| 加:投资收益 | 10,544,273.33 | 7,116,535.18 | 3,091,034.65 | -932,689.31 |
| 资产处置收益 | 3,398.23 | - | - | - |
| 资产减值损失(新) | -188,438.83 | -104,960.97 | - | - |
| 信用减值损失(新) | 239,188.28 | -1,495,049.39 | -683,961.47 | -668,422.46 |
| 其他收益 | 5,912,441.49 | 27,461,588.87 | 19,951,442.33 | 16,614,129.5 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 16,394,050.53 | -451,049,163 | -285,282,577.35 | -267,915,855.7 |
| 加:营业外收入 | - | 274,521.12 | 47,821.12 | 46,721.12 |
| 减:营业外支出 | - | 1,818,276.13 | 54,408.11 | 54,343.66 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 16,394,050.53 | -452,592,918.01 | -285,289,164.34 | -267,923,478.24 |
| 减:所得税费用 | 1,918,575.7 | 262,747.31 | 28,419.7 | 28,449.7 |
| 六、净利润 | 14,475,474.83 | -452,855,665.32 | -285,317,584.04 | -267,951,927.94 |
| 持续经营净利润 | 14,475,474.83 | -452,855,665.32 | -285,317,584.04 | -267,951,927.94 |
| 归属于母公司股东的净利润 | 17,967,628.89 | -440,632,966.49 | -275,409,931.99 | -261,840,060.1 |
| 少数股东损益 | -3,492,154.06 | -12,222,698.83 | -9,907,652.05 | -6,111,867.84 |
| (一)基本每股收益 | 0.01 | -0.26 | -0.16 | -0.16 |
| (二)稀释每股收益 | 0.01 | -0.26 | -0.16 | -0.16 |
| 八、其他综合收益 | -6,625,303.26 | 60,761,064.42 | -61,320,760.95 | 36,330,518.75 |
| 归属于母公司股东的其他综合收益 | -6,625,303.26 | 60,761,064.42 | -61,320,760.95 | 36,330,518.75 |
| 九、综合收益总额 | 7,850,171.57 | -392,094,600.9 | -346,638,344.99 | -231,621,409.19 |
| 归属于母公司股东的综合收益总额 | 11,342,325.63 | -379,871,902.07 | -336,730,692.94 | -225,509,541.35 |
| 归属于少数股东的综合收益总额 | -3,492,154.06 | -12,222,698.83 | -9,907,652.05 | -6,111,867.84 |
| 公告日期 | 2025-05-14 | 2025-03-28 | 2024-11-12 | 2024-08-21 |
| 审计意见(境内) | | 标准无保留意见 | | |